THE CONAFAY GROUP, LLC for CARY PHARMACEUTICALS
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Legislative initiatives relating to the GAIN Act and associated legislation, federal funding of biotechnology by the DoD, DHHS, NSF, and other similar agencies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHEN R CONAFAY New | — |
| MICHAEL SALGALLER New | — |
Budget/Appropriations BUD
Legislative initiatives relating to the GAIN Act and associated legislation, federal funding of biotechnology by the DoD, DHHS, NSF, and other similar agencies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHEN R CONAFAY New | — |
| MICHAEL SALGALLER New | — |
Medical/Disease Research/Clinical Labs MED
Legislative initiatives relating to the GAIN Act and associated legislation, federal funding of biotechnology by the DoD, DHHS, NSF, and other similar agencies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHEN R CONAFAY New | — |
| MICHAEL SALGALLER New | — |
Science/Technology SCI
Legislative initiatives relating to the GAIN Act and associated legislation, federal funding of biotechnology by the DoD, DHHS, NSF, and other similar agencies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHEN R CONAFAY New | — |
| MICHAEL SALGALLER New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.